Earnings Feed
Start Free
Home/Insiders/Morrell Martha
MM
SEC Insider//CIK 0001855616

Morrell Martha

CIK 00018556161 companyMOUNTAIN VIEW, CA
SEC Profile

Transactions

50

Companies

1

Filings

14

CIK

0001855616

Recent Transactions

50 trades
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2025-12-03$16.66/sh−1,338→ 78,734 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2025-11-27$16.50/sh−357→ 80,072 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2025-11-20$13.50/sh−3,051→ 80,429 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2025-09-03$9.36/sh−1,337→ 83,480 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2025-08-27$8.88/sh−357→ 84,817 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2025-08-20$8.66/sh−3,052→ 85,174 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2025-06-03$13.54/sh−1,338→ 85,943 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2025-05-27$12.66/sh−357→ 87,281 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2025-05-20$17.99/sh−3,051→ 87,638 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2025-04-22$10.94/sh−237→ 90,689 total
  • Award
    NeuroPace Inc$NPCE

    Common Stock

    2025-03-24+11,700→ 90,926 total
  • Award
    NeuroPace Inc$NPCE

    Stock Option (Right to Buy)

    2025-03-24+19,850→ 19,850 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2025-03-03$11.81/sh−1,337→ 79,226 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2025-02-27$12.56/sh−1,430→ 80,563 total
  • Sale
    NeuroPace Inc$NPCE

    Common Stock

    2025-02-21$13.72/sh−78,334→ 81,993 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2025-02-20$14.23/sh−3,405→ 43,670 total
  • Sale
    NeuroPace Inc$NPCE

    Common Stock

    2025-01-30$15.00/sh−200→ 86,762 total
  • Sale
    NeuroPace Inc$NPCE

    Common Stock

    2025-01-29$15.00/sh−100→ 86,962 total
  • Sale
    NeuroPace Inc$NPCE

    Common Stock

    2025-01-24$15.01/sh−3,200→ 87,062 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2025-01-22$14.04/sh−265→ 47,075 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2024-12-03$11.93/sh−1,413→ 47,340 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2024-11-20$9.19/sh−3,045→ 48,753 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2024-10-22$6.00/sh−237→ 51,798 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2024-09-03$7.39/sh−1,334→ 52,035 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2024-08-20$7.24/sh−3,045→ 53,369 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2024-07-22$7.65/sh−237→ 56,414 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2024-06-03$6.46/sh−1,335→ 56,511 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2024-05-20$7.98/sh−3,045→ 57,986 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2024-04-22$14.00/sh−237→ 61,268 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2024-03-03$15.99/sh−1,334→ 61,031 total
  • Award
    NeuroPace Inc$NPCE

    Common Stock

    2024-02-27+12,500→ 90,262 total
  • Award
    NeuroPace Inc$NPCE

    Stock Option (Right to Buy)

    2024-02-27+24,950→ 24,950 total
  • Tax Payment
    NeuroPace Inc$NPCE

    Common Stock

    2024-02-20$17.50/sh−12,474→ 62,602 total
  • Exercise/Conversion
    NeuroPace Inc$NPCE

    Common Stock

    2024-02-12$0.03/sh+50,000→ 160,327 total
  • Exercise/Conversion
    NeuroPace Inc$NPCE

    Stock Option (Rt to Buy)

    2024-02-12−50,000→ 140,449 total
  • Sale
    NeuroPace Inc$NPCE

    Common Stock

    2024-02-05$15.17/sh−3,446→ 77,762 total
  • Sale
    NeuroPace Inc$NPCE

    Common Stock

    2024-02-02$15.07/sh−14,143→ 81,208 total
  • Sale
    NeuroPace Inc$NPCE

    Common Stock

    2024-02-01$15.04/sh−663→ 95,351 total
  • Exercise/Conversion
    NeuroPace Inc$NPCE

    Stock Option (Rt to Buy)

    2024-01-31−192→ 0 total
  • Exercise/Conversion
    NeuroPace Inc$NPCE

    Stock Option (Rt to Buy)

    2024-01-31−192→ 0 total
  • Exercise/Conversion
    NeuroPace Inc$NPCE

    Common Stock

    2024-01-31$0.03/sh+192→ 44,054 total
  • Exercise/Conversion
    NeuroPace Inc$NPCE

    Common Stock

    2024-01-31$0.03/sh+40,000→ 96,480 total
  • Sale
    NeuroPace Inc$NPCE

    Common Stock

    2024-01-31$15.08/sh−1,923→ 96,014 total
  • Exercise/Conversion
    NeuroPace Inc$NPCE

    Common Stock

    2024-01-31$0.03/sh+12,234→ 56,480 total
  • Exercise/Conversion
    NeuroPace Inc$NPCE

    Stock Option (Rt to Buy)

    2024-01-31−192→ 192 total
  • Exercise/Conversion
    NeuroPace Inc$NPCE

    Common Stock

    2024-01-31$0.03/sh+192→ 43,862 total
  • Exercise/Conversion
    NeuroPace Inc$NPCE

    Common stock

    2024-01-31$0.03/sh+192→ 44,246 total
  • Exercise/Conversion
    NeuroPace Inc$NPCE

    Stock Option (Rt to Buy)

    2024-01-31−40,000→ 180,449 total
  • Exercise/Conversion
    NeuroPace Inc$NPCE

    Stock Option (Rt to Buy)

    2024-01-31−12,234→ 12,234 total
  • Sale
    NeuroPace Inc$NPCE

    Common Stock

    2024-01-30$15.10/sh−11,262→ 97,937 total

Companies

1

Recent Filings

14

Address

C/O NEUROPACE INC. 455 N. BERNARDO AVENUE

MOUNTAIN VIEW, CA, 94043

View on SEC.gov